Beta-Amyloid

Beta-amyloid is a protein fragment that accumulates abnormally in the brains of people with Alzheimer's disease. It is derived from a larger protein called amyloid precursor protein (APP). In Alzheimer's, beta-amyloid clumps together to form plaques, which disrupt communication between brain cells and contribute to their gradual dysfunction and death. This accumulation is believed to be one of the primary causes of Alzheimer's disease, leading to the characteristic symptoms of memory loss, cognitive decline, and behavioral changes.

Research suggests that beta-amyloid plaques may trigger a cascade of events, including inflammation and the formation of tangles of another protein called tau, which further damage and kill neurons. Understanding beta-amyloid's role is crucial for developing effective treatments to halt or slow the progression of Alzheimer's disease and related dementias. Current efforts focus on developing drugs that target beta-amyloid, as well as exploring preventive strategies and diagnostic tools to detect its presence early in the disease process.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp